Sandoz opens two new facilities; Gates Foundation funds needle-free vaccines; Novartis expands Japanese site
Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more.
Sandoz inaugurated two separate facilities in Austria and Germany dedicated to the production of penicillin and the development of biosimilars, respectively. The generic drugmaker invested €150 million ($163 million) in the Austrian site and €25 million ($27 million) in the German site. The openings “reaffirm the dual Sandoz commitment to ensuring sustainable access to quality antibiotics and spearheading development of biosimilars,” the company said in a Nov. 10 release.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.